15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection [Phesgo]
RxNorm concept 2382609, branded drug (sbd). Prescribable name: PHESGO 1,200 MG / 600 MG / 30,000 UNT in 15 ML Injection.
- RxCUI
- 2382609
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2382609 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Phesgo 1,200 MG / 600 MG / 30,000 UNT per 15 ML Injection
Related concepts
- hyaluronidase-zzxf 2000 UNT/ML (SCDC, consists of)
- pertuzumab-zzxf 80 MG/ML (SCDC, consists of)
- trastuzumab-zzxf 40 MG/ML (SCDC, consists of)
- hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML [Phesgo] (SBDC, consists of)
- Injection (DF, has dose form)
- Phesgo (BN, has ingredient)
- 15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2382609 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2382609 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2382609. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.